Posted On: 01/13/2016 9:18:43 AM
Post# of 63743
Here's the future of Fingerprint Technology and Medical Devices
$RXSF $3.15 Major Catalysts Coming >>
$25,000,000 Investment Bank Financing (3 Phase )
CVS In store Deal Upwards $10m for All 7,800 Stores
National Commercial Release for RX DrugSafe
IP Acquisitions/Company Acquisitions/Mergers
OEMS Partnerships Valued $3m+ Per Month (SafeDose), Thousands Available!
New Board Members
Ultimately Up Listing To NASDAQ with Fiscal 2016 Projection of $17.41 Very Conservative
**280,000 Float, No Dilution**
$RXSF $3.15 Major Catalysts Coming >>
$25,000,000 Investment Bank Financing (3 Phase )
CVS In store Deal Upwards $10m for All 7,800 Stores
National Commercial Release for RX DrugSafe
IP Acquisitions/Company Acquisitions/Mergers
OEMS Partnerships Valued $3m+ Per Month (SafeDose), Thousands Available!
New Board Members
Ultimately Up Listing To NASDAQ with Fiscal 2016 Projection of $17.41 Very Conservative
**280,000 Float, No Dilution**
(0)
(0)Scroll down for more posts ▼
